NFKB1 and astrocytoma (excluding glioblastoma): ENO1 has been shown to undergo substantial changes in astrocytoma tissues and is associated with the activation of NF-κB, modulation of E-cadherin expression, and the PI3K/AKT signaling pathway (Song et al., 2014).